Compounds and methods for modulating FXR

Details for Australian Patent Application No. 2008276236 (hide)

Owner Eli Lilly and Company

Inventors Manninen, Peter Rudolph; Genin, Michael James; Warshawsky, Alan M.; Agejas-Chicharro, Francisco Javier; Bueno Melendo, Ana Belen

Agent Spruson & Ferguson

Pub. Number AU-A-2008276236

PCT Pub. Number WO2009/012125

Priority 60/949,974 16.07.07 US

Filing date 11 July 2008

Wipo publication date 22 January 2009

International Classifications

C07D 261/08 (2006.01) Heterocyclic compounds having nitrogen and oxygen as the only ring hetero atoms

A61K 31/42 (2006.01) - Oxazoles

A61P 3/06 (2006.01) Drugs for disorders of the metabolism

C07D 413/12 (2006.01) Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms

Event Publications

24 December 2009 PCT application entered the National Phase

  PCT publication WO2009/012125 Priority application(s): WO2009/012125

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2008276240-Putters with enhanced alignment visualization

2008276211-Polynucleotide capture materials, and methods of using same